Gauri Shetye

705 total citations
37 papers, 500 citations indexed

About

Gauri Shetye is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Gauri Shetye has authored 37 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Infectious Diseases and 9 papers in Organic Chemistry. Recurrent topics in Gauri Shetye's work include Tuberculosis Research and Epidemiology (12 papers), Microbial Natural Products and Biosynthesis (7 papers) and Cancer therapeutics and mechanisms (6 papers). Gauri Shetye is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Microbial Natural Products and Biosynthesis (7 papers) and Cancer therapeutics and mechanisms (6 papers). Gauri Shetye collaborates with scholars based in United States, South Korea and India. Gauri Shetye's co-authors include Scott G. Franzblau, Sang‐Hyun Cho, Yan-Yeung Luk, Debjyoti Bandyopadhyay, Guirong Wang, Rui Ma, Joo‐Won Suh, Sijie Yang, Sankaranarayanan Murugesan and Shao‐Nong Chen and has published in prestigious journals such as PLoS ONE, Langmuir and Journal of Colloid and Interface Science.

In The Last Decade

Gauri Shetye

34 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gauri Shetye United States 12 288 182 146 94 82 37 500
Katsuhiko Mitachi United States 14 262 0.9× 136 0.7× 211 1.4× 71 0.8× 69 0.8× 33 531
Elena B. Isakova Russia 11 172 0.6× 104 0.6× 151 1.0× 115 1.2× 42 0.5× 30 367
Jiuyu Liu United States 14 388 1.3× 323 1.8× 170 1.2× 59 0.6× 166 2.0× 42 736
Nishad Thamban Chandrika United States 12 191 0.7× 143 0.8× 280 1.9× 80 0.9× 70 0.9× 28 548
David Degen United States 10 333 1.2× 136 0.7× 65 0.4× 96 1.0× 111 1.4× 13 504
Gopal R. Bommineni United States 13 296 1.0× 151 0.8× 159 1.1× 76 0.8× 52 0.6× 18 533
Yoshimasa Ishizaki Japan 9 179 0.6× 120 0.7× 75 0.5× 57 0.6× 64 0.8× 14 338
Suresh K. Tipparaju United States 11 252 0.9× 223 1.2× 273 1.9× 47 0.5× 161 2.0× 19 583
John N. Alumasa United States 17 313 1.1× 142 0.8× 242 1.7× 33 0.4× 48 0.6× 26 754
Aaron J. Peoples United States 9 412 1.4× 77 0.4× 80 0.5× 213 2.3× 40 0.5× 15 592

Countries citing papers authored by Gauri Shetye

Since Specialization
Citations

This map shows the geographic impact of Gauri Shetye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gauri Shetye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gauri Shetye more than expected).

Fields of papers citing papers by Gauri Shetye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gauri Shetye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gauri Shetye. The network helps show where Gauri Shetye may publish in the future.

Co-authorship network of co-authors of Gauri Shetye

This figure shows the co-authorship network connecting the top 25 collaborators of Gauri Shetye. A scholar is included among the top collaborators of Gauri Shetye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gauri Shetye. Gauri Shetye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kauffman, John F., José M. Cuevas, John Feiner, et al.. (2025). Discovery of ultra short β-peptoids with selective activity against drug-resistant Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 290. 117531–117531. 1 indexed citations
2.
Kumar, Tanweer, Yogesh Mahadu Khetmalis, Gauri Shetye, et al.. (2025). Exploration of quinoxaline triazoles as antimycobacterial agents: design, synthesis and biological evaluation. Bioorganic & Medicinal Chemistry Letters. 121. 130177–130177.
3.
Shetye, Gauri, Mallique Qader, A. G. Nugent, et al.. (2024). Discovery of New Cyclic Lipodepsipeptide Orfamide N via Partnership with Middle School Students from the Boys and Girls Club. ACS Omega. 9(44). 44749–44759.
4.
Wu, Zhen‐Long, Kyu‐Yeon Han, Gauri Shetye, et al.. (2023). Polyoxygenated cyclohexene derivatives and other constituents of Uvaria rufa stem. Phytochemistry. 216. 113884–113884. 3 indexed citations
5.
Bacik, J.P., Ruilian Wu, Ramesh K. Jha, et al.. (2022). Label-free affinity screening, design and synthesis of inhibitors targeting the Mycobacterium tuberculosis L-alanine dehydrogenase. PLoS ONE. 17(11). e0277670–e0277670. 4 indexed citations
6.
Liu, Rui, Kate Marshall, Rui Ma, et al.. (2022). Syntheses and studies of deuterated Imdiazo[1,2-a]pyridine-3-carboxamides with potent anti-tuberculosis activity and improved metabolic properties. Bioorganic Chemistry. 128. 106074–106074. 5 indexed citations
7.
Đức, Nguyễn Minh, Sang‐Hyun Cho, Gauri Shetye, et al.. (2022). Identification of the inhibitory mechanism of ecumicin and rufomycin 4-7 on the proteolytic activity of Mycobacterium tuberculosis ClpC1/ClpP1/ClpP2 complex. Tuberculosis. 138. 102298–102298. 8 indexed citations
8.
9.
Paik, Seungwha, Young Jae Kim, Jin Kyung Kim, et al.. (2021). Rufomycin Exhibits Dual Effects Against Mycobacterium abscessus Infection by Inducing Host Defense and Antimicrobial Activities. Frontiers in Microbiology. 12. 695024–695024. 9 indexed citations
10.
Khetmalis, Yogesh Mahadu, Banoth Karan Kumar, Sankaranarayanan Murugesan, et al.. (2021). Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis. Toxicology in Vitro. 74. 105137–105137. 24 indexed citations
11.
Liu, Rui, Lowell D. Markley, Patricia A. Miller, et al.. (2021). Hydride-induced Meisenheimer complex formation reflects activity of nitro aromatic anti-tuberculosis compounds. RSC Medicinal Chemistry. 12(1). 62–72. 6 indexed citations
12.
Shetye, Gauri, Scott G. Franzblau, & Sang‐Hyun Cho. (2020). New tuberculosis drug targets, their inhibitors, and potential therapeutic impact. Translational research. 220. 68–97. 124 indexed citations
13.
Hương, Đoàn Thị Mai, Mai Anh Nguyen, Van Minh Chau, et al.. (2019). Antimicrobial Lavandulylated Flavonoids from a Sponge-Derived Streptomyces sp. G248 in East Vietnam Sea. Marine Drugs. 17(9). 529–529. 26 indexed citations
14.
Shetye, Gauri, et al.. (2017). Synthetic analogs of rhamnolipids modulate structured biofilms formed by rhamnolipid-nonproducing mutant of Pseudomonas aeruginosa. Bioorganic & Medicinal Chemistry. 25(6). 1830–1838. 17 indexed citations
15.
16.
Yang, Sijie, Osama Abdel‐Razek, Fei Cheng, et al.. (2014). Bicyclic brominated furanones: A new class of quorum sensing modulators that inhibit bacterial biofilm formation. Bioorganic & Medicinal Chemistry. 22(4). 1313–1317. 28 indexed citations
17.
Shetye, Gauri, et al.. (2013). The ability of single-chain surfactants to emulsify an aqueous-based liquid crystal oscillates with odd–even parity of alkyl-chain length. Journal of Colloid and Interface Science. 412. 95–99. 8 indexed citations
18.
Shetye, Gauri, et al.. (2013). Structures and biofilm inhibition activities of brominated furanones for Escherichia coli and Pseudomonas aeruginosa. MedChemComm. 4(7). 1079–1079. 24 indexed citations
19.
20.
Simon, Karen A., Gauri Shetye, U. Englich, Lei Wu, & Yan-Yeung Luk. (2011). Noncovalent Polymerization of Mesogens Crystallizes Lysozyme: Correlation between Nonamphiphilic Lyotropic Liquid Crystal Phase and Protein Crystal Formation. Langmuir. 27(17). 10901–10906. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katsuhiko Mitachi Breakdown of academic impact, for papers by Elena B. Isakova Breakdown of academic impact, for papers by Jiuyu Liu Breakdown of academic impact, for papers by Nishad Thamban Chandrika Breakdown of academic impact, for papers by David Degen Breakdown of academic impact, for papers by Gopal R. Bommineni Breakdown of academic impact, for papers by Yoshimasa Ishizaki Breakdown of academic impact, for papers by Suresh K. Tipparaju Breakdown of academic impact, for papers by John N. Alumasa Breakdown of academic impact, for papers by Aaron J. Peoples
Rankless by CCL
2026